Elanco Animal Health (ELAN) Tops Q4 EPS by 88c, Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $1.05, $0.88 better than the analyst estimate of $0.17. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.1 billion.

GUIDANCE:

Elanco Animal Health sees Q1 2022 EPS of $0.33-$0.38, versus the consensus of $0.37. Elanco Animal Health sees Q1 2022 revenue of $1.2-1.23 billion, versus the consensus of $1.25 billion.

Elanco Animal Health sees FY2022 EPS of $1.18-$1.24, versus the consensus of $1.22. Elanco Animal Health sees FY2022 revenue of $4.745-4.8 billion, versus the consensus of $4.86 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• AeroVironment restates quarterly financials, citing $89M goodwill error